FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2412683951> ?p ?o ?g. }

• W2412683951 endingPage "91" @default.
• W2412683951 startingPage "80" @default.
• W2412683951 abstract "In Brief The effects of ultramicronized palmitoylethanolamide were evaluated on pain behaviours and markers of mast cell (MC) activity in a rat model of endometriosis plus ureteral calculosis (ENDO+STONE)–induced viscerovisceral hyperalgesia (VVH). Female Sprague-Dawley rats that underwent surgical induction of endometriosis were randomly assigned to receive active (ultramicronized palmitoylethanolamide 10 mg·kg−1·d−1, orally) or placebo treatment for 25 days. At day 21, they underwent ureteral stone formation and were video-recorded till day 25 to evaluate ureteral and uterine pain behaviours. At autopsy (day 25), ureteral condition and number and diameter of endometrial cysts were evaluated. The following were then measured: number and percentage of degranulating MCs, number of vessels, chymase, nerve growth factor (NGF), vascular endothelial growth factor (VEGF), and Flk-1 (VEGF receptor) in cysts, and NGF in dorsal root ganglia (DRG). Ultramicronized palmitoylethanolamide–treated vs placebo-treated rats showed significantly lower number, duration and complexity of ureteral crises, shorter duration of uterine pain, and smaller cyst diameter (0.0001 < P < 0.004); a significantly higher percentage of expelled stones (P < 0.0001); significantly lower MC number (P < 0.01), vessel number (P < 0.01), chymase (P < 0.05), NGF (P < 0.05), VEGF (P < 0.01), and Flk-1 (P < 0.01) expression in cysts and NGF expression in DRG (P < 0.01). In all animals, the global duration of ureteral crises correlated linearly and directly with cyst diameter, MC number and chymase in cysts, and NGF in cysts and DRG (0.02 < P < 0.0002). Ultramicronized palmitoylethanolamide significantly reduces VVH from ENDO+STONE, probably by modulating MC expression/activity in cysts, thus reducing central sensitization due to noxious signals from endometriotic lesions. The results suggest potential utility of the compound for VVH in clinics. In rats with endometriosis plus ureteral calculosis, oral ultramicronized palmitoylethanolamide vs placebo significantly reduces viscerovisceral hyperalgesia by downregulating mast cell activity in endometriotic lesions." @default.
• W2412683951 created "2016-06-24" @default.
• W2412683951 creator A5001907526 @default.
• W2412683951 creator A5002033752 @default.
• W2412683951 creator A5006312872 @default.
• W2412683951 creator A5011391571 @default.
• W2412683951 creator A5023999301 @default.
• W2412683951 creator A5039818353 @default.
• W2412683951 creator A5062330127 @default.
• W2412683951 creator A5062733124 @default.
• W2412683951 creator A5065606348 @default.
• W2412683951 creator A5077410231 @default.
• W2412683951 creator A5082265601 @default.
• W2412683951 creator A5091279922 @default.
• W2412683951 date "2016-01-01" @default.
• W2412683951 modified "2023-10-14" @default.
• W2412683951 title "Ultramicronized palmitoylethanolamide reduces viscerovisceral hyperalgesia in a rat model of endometriosis plus ureteral calculosis" @default.
• W2412683951 cites W1498357119 @default.
• W2412683951 cites W1550668938 @default.
• W2412683951 cites W1910345130 @default.
• W2412683951 cites W1966257589 @default.
• W2412683951 cites W1969248212 @default.
• W2412683951 cites W1977003241 @default.
• W2412683951 cites W1978798118 @default.
• W2412683951 cites W1981400857 @default.
• W2412683951 cites W1984988711 @default.
• W2412683951 cites W1990177635 @default.
• W2412683951 cites W1992445235 @default.
• W2412683951 cites W1998941878 @default.
• W2412683951 cites W2001078159 @default.
• W2412683951 cites W2005257484 @default.
• W2412683951 cites W2005376021 @default.
• W2412683951 cites W2009567157 @default.
• W2412683951 cites W2013356266 @default.
• W2412683951 cites W2017025746 @default.
• W2412683951 cites W2018503742 @default.
• W2412683951 cites W2021337250 @default.
• W2412683951 cites W2024009202 @default.
• W2412683951 cites W2028537447 @default.
• W2412683951 cites W2030362768 @default.
• W2412683951 cites W2033247060 @default.
• W2412683951 cites W2033814351 @default.
• W2412683951 cites W2035174036 @default.
• W2412683951 cites W2039306587 @default.
• W2412683951 cites W2039446928 @default.
• W2412683951 cites W2054322334 @default.
• W2412683951 cites W2061803246 @default.
• W2412683951 cites W2062146531 @default.
• W2412683951 cites W2074116484 @default.
• W2412683951 cites W2076195364 @default.
• W2412683951 cites W2078828516 @default.
• W2412683951 cites W2082956393 @default.
• W2412683951 cites W2085438111 @default.
• W2412683951 cites W2085922363 @default.
• W2412683951 cites W2090706382 @default.
• W2412683951 cites W2091478079 @default.
• W2412683951 cites W2108842395 @default.
• W2412683951 cites W2110802986 @default.
• W2412683951 cites W2111276435 @default.
• W2412683951 cites W2115041299 @default.
• W2412683951 cites W2115082669 @default.
• W2412683951 cites W2117073896 @default.
• W2412683951 cites W2117120599 @default.
• W2412683951 cites W2125410210 @default.
• W2412683951 cites W2126728673 @default.
• W2412683951 cites W2128514007 @default.
• W2412683951 cites W2129287765 @default.
• W2412683951 cites W2137876945 @default.
• W2412683951 cites W2138898702 @default.
• W2412683951 cites W2145115417 @default.
• W2412683951 cites W2145373054 @default.
• W2412683951 cites W2146493861 @default.
• W2412683951 cites W2158102618 @default.
• W2412683951 cites W2162237613 @default.
• W2412683951 cites W2165128851 @default.
• W2412683951 cites W2166728827 @default.
• W2412683951 cites W2168963576 @default.
• W2412683951 cites W2314555581 @default.
• W2412683951 cites W2985833654 @default.
• W2412683951 doi "https://doi.org/10.1097/j.pain.0000000000000220" @default.
• W2412683951 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25974242" @default.
• W2412683951 hasPublicationYear "2016" @default.
• W2412683951 type Work @default.
• W2412683951 sameAs 2412683951 @default.
• W2412683951 citedByCount "35" @default.
• W2412683951 countsByYear W24126839512015 @default.
• W2412683951 countsByYear W24126839512016 @default.
• W2412683951 countsByYear W24126839512017 @default.
• W2412683951 countsByYear W24126839512018 @default.
• W2412683951 countsByYear W24126839512019 @default.
• W2412683951 countsByYear W24126839512020 @default.
• W2412683951 countsByYear W24126839512021 @default.
• W2412683951 countsByYear W24126839512022 @default.
• W2412683951 countsByYear W24126839512023 @default.
• W2412683951 crossrefType "journal-article" @default.
• W2412683951 hasAuthorship W2412683951A5001907526 @default.
• W2412683951 hasAuthorship W2412683951A5002033752 @default.
• W2412683951 hasAuthorship W2412683951A5006312872 @default.

• next